OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
12
Results
Show all
Save search
Copy query
Show results for
Unknown
(12)
Publication Date
Release Date
2024
(3)
2025
(2)
2022
(2)
2026
(1)
2021
(1)
2019
(1)
2016
(1)
2012
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
HHLA2 is a novel immune checkpoint protein in pancreatic ductal adenocarcinoma and predicts post-surgical survival.
Not available
S-EPMC6357962
|
biostudies-literature
Cite
IP
6
-assisted CSN-COP1 competition regulates a CRL4-ETV5 proteolytic checkpoint to safeguard glucose-induced insulin secretion.
Not available
S-EPMC8080631
|
biostudies-literature
Cite
Ultrahigh-energy gamma-ray emission associated with black hole-jet systems.
Not available
S-EPMC12746838
|
biostudies-literature
Cite
Probing CP symmetry and weak phases with entangled double-strange baryons.
Not available
S-EPMC9159954
|
biostudies-literature
Cite
Extracting the femtometer structure of strange baryons using the vacuum polarization effect.
Not available
S-EPMC11470094
|
biostudies-literature
Cite
Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry.
Not available
S-EPMC10830583
|
biostudies-literature
Cite
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Not available
S-EPMC4835977
|
biostudies-literature
Cite
Observation of quantum entanglement with top quarks at the ATLAS detector.
Not available
S-EPMC11410654
|
biostudies-literature
Cite
Using CSF biomarkers to replicate genetic associations in Alzheimer's disease.
Not available
S-EPMC3150628
|
biostudies-literature
Cite
Transforming jet flavour tagging at ATLAS.
Not available
S-EPMC12804921
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets